A Prospective, Multicenter Phase II Study of Consolidation with Cyclophosphamide, Bortezomib and Dexamethasone (CVD) in Patients with Multiple Myeloma after Autologous Stem Cell Transplantation; The KMM130 Study

Authors :: Sang Kyun Sohn
Jongheon Jung
Ho-Jin Shin
Chang-Ki Min
Sung-Soo Yoon
Jin Seok Kim
Soo Mee Bang
Jae Hoon Lee
Hyeon-Seok Eom
Cheolwon Suh
Je-Jung Lee
Kihyun Kim
Source :: Clinical Lymphoma Myeloma and Leukemia. 19:e291
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Cyclophosphamide
Bortezomib
business.industry
Phases of clinical research
Hematology
medicine.disease
Autologous stem-cell transplantation
Internal medicine
medicine
In patient
business
Dexamethasone
Multiple myeloma
medicine.drug

Tools